Request Trial
7 December 2017Pharma

Advocate general gives opinion on data exclusivity

An advocate general (AG) has said that regulatory authorities in “concerned” EU member states handling drug marketing authorisations (MAs) are co-responsible for approved documents on data exclusivity.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
MSD’s Keytruda hit by eight-country ban across Europe
8 October 2026   Rival Halozyme secures a major patent victory against the pharma giant, blocking the subcutaneous version of its blockbuster cancer drug Keytruda across eight countries as MSD faces mounting pressure ahead of key patent expirations.
Pharma
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
6 October 2026   Day one of the UK patent trial over blockbuster drug Jardiance put a lack of biological data, disputed evidence of testing and the limits of scientific prediction under the spotlight.
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026   The decision leaves a $177 million verdict against Lilly intact, but a dissenting judge has warned the ruling could “undermine medical innovation” by allowing overly broad patent claims to survive and provide a way around the Supreme Court’s Amgen decision.


Editor's picks

Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
Pharma
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
6 October 2026

Editor's picks

Pharma
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
6 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026
Pharma
Behind the case: How Novartis defended its blockbuster Entresto in the UK
22 September 2026
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026
Regulation & Industry
Perfect Pitch: Inside the scheme that gets junior lawyers selling to clients
14 September 2026

More features

MSD’s Keytruda hit by eight-country ban across Europe
WATCH: LEO Pharma head of IP rights on doing more with less
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
Latham adds ‘exceptional’ ITC expert and 5th trial lawyer in a year
Roche, Marques counsel: The fight against ‘deadly’ counterfeits is a race for the newest and best tech
Fish & Richardson nets patent litigator to grow European practice
What's AI best at? In-house teams are still learning
WATCH: Genevant IP director on tackling UPC-EPO opposition divide